Pharmaceuticals stocks with little or no debt
| Company | CMP (Rs) | D/E (Curr FY, x) | Total Debt (Curr FY, Rs m) | MCap (Rs m) | P/E (x) | P/BV (x) | Profit CAGR (3 yrs, %) |
|---|---|---|---|---|---|---|---|
| ASTRAZENECA PHARMA | 6,359.7 | 0.0 | 0 | 158,991 | 194.1 | 23.2 | 20.1% |
| ACHYUT HEALTHCARE | 67.0 | 0.0 | 0 | 1,127 | NM | 3.7 | 277.9% |
| BRAWN BIOTECH | 21.0 | 0.0 | 0 | 63 | NM | 1.5 | NM |
| CHEMO PHARMA | 81.0 | 0.0 | 0 | 122 | 9.8 | 0.9 | 68.7% |
| COMBAT DRUGS | 15.4 | 0.0 | 0 | 155 | 18.7 | 0.7 | NM |
| CORAL LAB. | 780.0 | 0.0 | 0 | 2,786 | 12.0 | 1.4 | 5.2% |
| DHANVANTRI JEEV | 20.7 | 0.0 | 0 | 85 | 14.2 | 0.9 | NM |
| DIVIS LABORATORIES | 6,019.0 | 0.0 | 0 | 1,597,855 | 87.0 | 11.5 | NM |
| EARUM PHARMACEUTICALS | 1.8 | 0.0 | 0 | 1,227 | 65.9 | 0.7 | NM |
| PROCTER & GAMBLE HEALTH | 5,078.8 | 0.0 | 0 | 84,304 | 38.7 | 13.8 | 4.4% |
| FERVENT SYNERGIES | 15.7 | 0.0 | 0 | 470 | NM | 1.5 | NM |
| GUJ.INJ(KER) | 19.1 | 0.0 | 0 | 280 | 36.1 | 2.9 | NM |
| GUJ.THEMIS. | 314.0 | 0.0 | 0 | 34,210 | 64.9 | 15.5 | 25.2% |
| GLENMARK LIFE SCIENCES | 1,078.1 | 0.0 | 0 | 132,103 | 31.2 | 5.2 | 10.2% |
| GSK PHARMA | 2,377.7 | 0.0 | 0 | 402,788 | 59.7 | 24.1 | 27.1% |
| SANOFI INDIA | 6,062.2 | 0.0 | 0 | 139,616 | 32.9 | 18.2 | 8.1% |
| INDRAPRASTHA MEDICAL | 426.6 | 0.0 | 0 | 39,103 | 26.5 | 7.3 | 276.1% |
| ISHITA DRUGS | 74.0 | 0.0 | 0 | 221 | 29.9 | 2.1 | NM |
| JENBURKT PH. | 1,144.0 | 0.0 | 0 | 5,049 | 16.7 | 3.2 | 16.3% |
| JAGSON PHAR | 642.1 | 0.0 | 0 | 17,024 | 70.0 | 8.0 | 9.6% |
| ABBOTT INDIA | 27,300.2 | 0.0 | 0 | 580,110 | 45.2 | 16.4 | 20.3% |
| MEDI CAPS | 51.2 | 0.0 | 0 | 638 | NM | 0.5 | NM |
| LOOKS HEALTH SERVICES | 5.1 | 0.0 | 0 | 54 | NM | 0.4 | NM |
| FORTIS MALAR | 53.4 | 0.0 | 0 | 1,000 | 2.0 | 3.3 | NM |
| METROPOLIS HEALTHCARE | 2,023.4 | 0.0 | 0 | 103,734 | 69.8 | 8.7 | NM |
* We show NM where the values are negative
Disclaimer: This is for information purposes only. These are not stock recommendations and should not be treated as such. Learn more about our recommendation services here... Also note that these screeners are based only on numbers. There is no screening for management quality.
Equitymaster's powerful BSE/NSE Stock Screener allows you to screen stocks based on both pre-set and your own criteria.